RootPath is a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude. Our molecular programming-based DNA fragment assembly technology gives researchers and drug developers unprecedented, equitable access to long synthetic genes and their functional readouts. As its first application, we utilize our technology to mine a patient’s immunome and create truly personalized T cell therapies for solid tumors. Together, with leading partners, we are exploring new applications across multiple industries. We enable biology at scale.
WATERTOWN, Mass.--(BUSINESS WIRE)--RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced that CEO and Co-Founder, Xi Chen, will present an overview of RootPath’s gene synthesis platform PathFinder DNA Assembly™ and Nano Toothpick™ at the Built With Biology Conference on April 13, 2022 at 12:30 pm PDT in Oakland, California. Susana Donkor, a research associate at RootPath, will participate in a fireside chat at the Built With Biology Conference on April 12, 2022 at 5:25 PM PDT.